0.5899
price down icon1.63%   -0.0098
after-market After Hours: .59 0.000100 +0.02%
loading
Reviva Pharmaceuticals Holdings Inc stock is traded at $0.5899, with a volume of 6.34M. It is down -1.63% in the last 24 hours and up +8.24% over the past month. Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
See More
Previous Close:
$0.5997
Open:
$0.62
24h Volume:
6.34M
Relative Volume:
0.72
Market Cap:
$40.90M
Revenue:
-
Net Income/Loss:
$-27.11M
P/E Ratio:
-0.9075
EPS:
-0.65
Net Cash Flow:
$-26.55M
1W Performance:
-0.29%
1M Performance:
+8.24%
6M Performance:
-31.95%
1Y Performance:
-39.65%
1-Day Range:
Value
$0.57
$0.6499
1-Week Range:
Value
$0.55
$0.6499
52-Week Range:
Value
$0.2522
$4.28

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile

Name
Name
Reviva Pharmaceuticals Holdings Inc
Name
Phone
(408) 501-8881
Name
Address
10080 N WOLFE ROAD, CUPERTINO
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
RVPH's Discussions on Twitter

Compare RVPH with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RVPH
Reviva Pharmaceuticals Holdings Inc
0.5899 57.77M 0 -27.11M -26.55M -0.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-29-25 Initiated Chardan Capital Markets Buy
Sep-20-23 Initiated ROTH MKM Buy
Jun-08-23 Initiated The Benchmark Company Speculative Buy
Jan-24-22 Initiated H.C. Wainwright Buy

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Latest News

pulisher
10:03 AM

Price action breakdown for Reviva Pharmaceuticals Holdings Inc. Equity WarrantQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - newser.com

10:03 AM
pulisher
09:56 AM

Is Reviva Pharmaceuticals Holdings Inc. forming a bottoming basePortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com

09:56 AM
pulisher
09:36 AM

Visual trend scoring systems applied to Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Trends & Precise Swing Trade Entry Alerts - newser.com

09:36 AM
pulisher
09:02 AM

What indicators show strength in Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Trends & High Conviction Trade Alerts - newser.com

09:02 AM
pulisher
08:12 AM

Has Reviva Pharmaceuticals Holdings Inc. found a price floorJuly 2025 EndofMonth & Low Drawdown Momentum Ideas - newser.com

08:12 AM
pulisher
08:00 AM

How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock trades before earningsMarket Growth Review & High Conviction Investment Ideas - newser.com

08:00 AM
pulisher
07:59 AM

Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock affected by interest rate hikes2025 Sector Review & Safe Capital Preservation Plans - newser.com

07:59 AM
pulisher
07:15 AM

What recovery options are there for Reviva Pharmaceuticals Holdings Inc.July 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com

07:15 AM
pulisher
06:46 AM

Applying Elliott Wave Theory to Reviva Pharmaceuticals Holdings Inc. Equity WarrantTrade Exit Report & Technical Entry and Exit Alerts - newser.com

06:46 AM
pulisher
06:20 AM

How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock performs after earningsQuarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com

06:20 AM
pulisher
03:17 AM

Risk adjusted return profile for Reviva Pharmaceuticals Holdings Inc. Equity Warrant analyzedBuy Signal & Accurate Entry and Exit Point Alerts - newser.com

03:17 AM
pulisher
03:11 AM

Published on: 2025-11-03 02:11:00 - newser.com

03:11 AM
pulisher
03:08 AM

Published on: 2025-11-03 02:08:28 - newser.com

03:08 AM
pulisher
02:51 AM

Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock dividend yield sustainableEarnings Miss & High Conviction Investment Ideas - newser.com

02:51 AM
pulisher
02:39 AM

Statistical indicators supporting Reviva Pharmaceuticals Holdings Inc.’s strengthTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com

02:39 AM
pulisher
02:23 AM

Long term hold vs stop loss in Reviva Pharmaceuticals Holdings Inc.July 2025 Opening Moves & Community Driven Trade Alerts - newser.com

02:23 AM
pulisher
01:47 AM

Order flow analysis tools used on Reviva Pharmaceuticals Holdings Inc. Equity WarrantJuly 2025 Volume & Consistent Profit Trading Strategies - newser.com

01:47 AM
pulisher
01:19 AM

Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reach all time highs in 2025Quarterly Earnings Summary & Real-Time Volume Analysis - newser.com

01:19 AM
pulisher
Nov 02, 2025

Why Reviva Pharmaceuticals Holdings Inc. stock is popular among millennialsMarket Trend Report & Community Verified Watchlist Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Key resistance and support levels for Reviva Pharmaceuticals Holdings Inc.July 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

What drives Namura Shipbuilding Co Ltd 8AF stock priceMarket Timing Techniques & Learn What Analysts Rate “Strong Buy” - earlytimes.in

Nov 02, 2025
pulisher
Nov 02, 2025

Forecasting Reviva Pharmaceuticals Holdings Inc. Equity Warrant price range with options dataWeekly Investment Recap & Fast Moving Market Watchlists - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Price momentum metrics for Reviva Pharmaceuticals Holdings Inc. Equity Warrant explained2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is it time to cut losses on Reviva Pharmaceuticals Holdings Inc.Quarterly Performance Summary & Technical Pattern Based Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Intraday pattern recognizer results for Reviva Pharmaceuticals Holdings Inc. Equity WarrantTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Published on: 2025-11-02 12:27:45 - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Reviva Pharmaceuticals Holdings Inc. stock positioned for digital transformationTrade Entry Summary & Weekly Breakout Stock Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock chart pattern explainedPortfolio Value Summary & AI Optimized Trading Strategy Guides - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Historical volatility pattern of Reviva Pharmaceuticals Holdings Inc. visualizedPrice Action & AI Driven Stock Movement Reports - newser.com

Nov 01, 2025

Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Cap:     |  Volume (24h):